Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hepatitis01:25

Hepatitis

59
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
59
Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

613
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
613
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

1.4K
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
1.4K
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

35
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
35
Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

743
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
743

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hepatitis delta virus RNA decline post-inoculation in human NTCP transgenic mice is biphasic.

mBio·2023
Same author

Hepatitis delta virus RNA decline post inoculation in human NTCP transgenic mice is biphasic.

bioRxiv : the preprint server for biology·2023
Same author

Safety of transanal ileal pouch-anal anastomosis for ulcerative colitis: a retrospective observational cohort study.

Patient safety in surgery·2021
Same author

An elevated FIB-4 score predicts liver cancer development: A longitudinal analysis from 29,999 patients with NAFLD.

Journal of hepatology·2021
Same author

Circulating Osteopontin Levels and Outcomes in Patients Hospitalized for COVID-19.

Journal of clinical medicine·2021
Same author

Elevated Flt3L Predicts Long-Term Survival in Patients with High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms.

Cancers·2021

Related Experiment Video

Updated: Apr 12, 2026

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System
05:55

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System

Published on: December 21, 2019

7.3K

Molecular interactions between hepatitis B virus and delta virus.

Elham Shirvani-Dastgerdi1, Frank Tacke1

  • 1Elham Shirvani-Dastgerdi, Frank Tacke, Department of Medicine III, University Hospital Aachen, 52074 Aachen, Germany.

World Journal of Virology
|May 13, 2015
PubMed
Summary

Hepatitis D virus (HDV) requires hepatitis B virus (HBV) envelope proteins for infection. This study explores molecular interactions between HDV and HBV, revealing mechanisms that control viral replication for potential delta hepatitis therapies.

Keywords:
Ag loopHepatitis B virusHepatitis B virus surface antigensHepatitis D virusHepatitis D virus antigenLiver cirrhosisViral hepatitis

More Related Videos

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection
11:14

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection

Published on: November 7, 2018

19.0K
A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.8K

Related Experiment Videos

Last Updated: Apr 12, 2026

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System
05:55

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System

Published on: December 21, 2019

7.3K
Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection
11:14

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection

Published on: November 7, 2018

19.0K
A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.8K

Area of Science:

  • Virology
  • Hepatology
  • Molecular Biology

Background:

  • Hepatitis D virus (HDV) is an obligate parasite requiring hepatitis B virus (HBV) for replication and causing severe liver disease.
  • HDV relies on HBV's small (S), medium (M), and large (L) envelope proteins (HBsAgs) for its own envelopment.
  • The precise molecular interactions between HDV and HBsAgs, particularly the S protein, remain incompletely defined.

Purpose of the Study:

  • To elucidate the molecular interaction sites between HBsAg and the HDV ribonucleoprotein (RNP) complex.
  • To investigate the mechanisms by which HDV influences HBV replication.
  • To identify potential therapeutic targets for delta hepatitis.

Main Methods:

  • Analysis of molecular interactions between viral proteins.
  • Review of existing literature on HBV-HDV co-infection.
  • Discussion of proposed mechanisms of viral replication control.

Main Results:

  • Identified specific interaction sites and "hot spots" between HBsAg and HDV-RNP complex.
  • Demonstrated that HDV actively inhibits HBV-DNA replication while promoting selective HBV protein transcription.
  • Highlighted the dual role of HBV envelope proteins in facilitating HDV envelopment and being targeted by HDV.

Conclusions:

  • Understanding the intricate molecular interplay between HBV and HDV is crucial for developing effective treatments for delta hepatitis.
  • HDV employs sophisticated mechanisms to manipulate HBV replication, suggesting complex co-evolutionary strategies.
  • Targeting these molecular interactions could lead to novel antiviral therapies against HDV infection.